In Acadia Pharms., Inc. v. Aurobindo Pharma Ltd., No. 20-985-GBW (D. Del. Dec. 2023), the district court granted Acadia's motion for summary judgment of no invalidity.
The President’s recent Executive Order on the Safe, Secure, and Trustworthy Development and Use of Artificial Intelligence instructs the USPTO Director and Copyright Registrar to collaboratively issue recommendations to the President on further actions for advancing AI innovation through intellectual property.
The biopharmaceutical and healthcare fields produce massive amounts of data.. AI systems trained on such data can streamline and optimize the drug development process.
In its appeal from an adverse decision on priority by the Patent Trial and Appeal Board (PTAB) in Interference No. 106,115 (directed to CRISPR-mediated gene editing), Junior Party the.
In a patent infringement lawsuit brought under the Hatch-Waxman Act, the district court in the Northern District of West Virginia recently denied Plaintiffs Bausch Health Ireland Limited.